Amphastar Pharmaceuticals AMPH
NASDAQ AMPH
$22.75 -0.18 (-0.78%)
As of: Sep 9, 2026 · 1:42 PM EDT

Amphastar Pharmaceuticals (AMPH) EBT Margin (QoQ) (2013 - 2026)

Analysis

Amphastar Pharmaceuticals (AMPH) EBT Margin (QoQ) (2013 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 42.56 Bn 38.90 Bn 2.15 Bn
2 Viatris 19.13 Bn 18.24 Bn 1.46 Bn
3 Dr Reddys Laboratories 9.86 Bn 9.69 Bn 396.53 Mn
4 Amneal Pharmaceuticals 5.46 Bn 5.33 Bn 334.51 Mn
5 Bausch Health Companies 2.37 Bn 528.25 Mn 2.10 Bn
6 Alvotech 1.51 Bn 1.37 Bn 2.56 Mn
7 Ani Pharmaceuticals 1.49 Bn 1.13 Bn 165.89 Mn
8 Amphastar Pharmaceuticals 992.90 Mn 702.78 Mn 93.47 Mn
9 Fennec Pharmaceuticals 411.43 Mn 370.18 Mn 17.15 Mn
10 RedHill Biopharma 181.39 Mn 181.39 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1,509.00
Mar 31, 2026 -1,447.00
Dec 31, 2025 913.00
Sep 30, 2025 -1,134.00
Jun 30, 2025 445.00
Mar 31, 2025 -837.00
Dec 31, 2024 153.00
Sep 30, 2024 -261.00
Jun 30, 2024 -32.00
Mar 31, 2024 -128.00
Dec 31, 2023 -610.00
Sep 30, 2023 1,273.00
Jun 30, 2023 -146.00
Mar 31, 2023 -1,485.00
Dec 31, 2022 2,002.00
Sep 30, 2022 6.00
Jun 30, 2022 -537.00
Mar 31, 2022 165.00
Dec 31, 2021 -1,108.00
Sep 30, 2021 1,957.00